BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 19033246)

  • 1. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
    Preisler A; Mraheil MA; Heisig P
    J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    FEMS Microbiol Lett; 2004 Sep; 238(1):267-72. PubMed ID: 15336432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
    Peterson ML; Rotschafer JC; Piddock LJ
    J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
    Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.
    de Toro M; Rojo-Bezares B; Vinué L; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1945-9. PubMed ID: 20639314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
    Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
    J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
    Angelakis E; Biswas S; Taylor C; Raoult D; Rolain JM
    J Antimicrob Chemother; 2008 Jun; 61(6):1252-5. PubMed ID: 18334491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Ge B; McDermott PF; White DG; Meng J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3347-54. PubMed ID: 16048946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I; Kay E; Schneider D; Maurin M
    J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks.
    Baucheron S; Mouline C; Praud K; Chaslus-Dancla E; Cloeckaert A
    J Antimicrob Chemother; 2005 May; 55(5):707-12. PubMed ID: 15814604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium.
    Blair JM; La Ragione RM; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2009 Nov; 64(5):965-72. PubMed ID: 19744979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.
    Baucheron S; Chaslus-Dancla E; Cloeckaert A
    J Antimicrob Chemother; 2004 Apr; 53(4):657-9. PubMed ID: 14985270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.